Mar 23 Are COVID vaccines for little kids coming soon? Here’s what to know By Lauran Neergaard, Associated Press Early study results released Wednesday by Moderna suggest the two small doses work in tots younger than 6. Continue reading
Mar 15 Pfizer asks U.S. to approve a 4th COVID vaccine dose for seniors By Zeke Miller, Lauran Neergaard, Associated Press If the government approves the request, made by the company Tuesday, a key question would be how soon seniors would be advised to roll up their sleeves, given that cases currently are dropping. Continue reading
Mar 01 Pfizer vaccine effective against severe COVID-19 for children between 5 and 11, CDC says By Lauran Neergaard, Associated Press A new government report shows Pfizer's COVID-19 vaccine gave children 5 and older strong protection against hospitalization and death even during the omicron surge. Continue reading
Feb 11 More data needed on Pfizer’s COVID-19 vaccine for kids under 5, FDA says By Lauran Neergaard, Matthew Perrone, Associated Press The Food and Drug Administration had urged Pfizer and its partner BioNTech to apply for authorization of extra-low doses of its vaccine for the youngest children before clinical studies were finished. On Friday, the FDA reversed course. Continue reading
Feb 01 Pfizer asks FDA to allow COVID-19 vaccine for children under 5 By Matthew Perrone, Lauran Neergaard, Associated Press Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March. Continue reading
Jan 25 Watch 5:16 News Wrap: Pfizer starts clinical trial of omicron-based vaccine In our news wrap Tuesday, Pfizer began a clinical trial of an updated COVID-19 vaccine designed to ward off the highly contagious omicron variant. The International Monetary Fund slashed its growth forecast citing the omicron variant and other factors. London's… Continue watching
Jan 25 New Pfizer study to test omicron-specific vaccine By Lauran Neergaard, Associated Press Pfizer and BioNTech have begun studying a COVID-19 vaccine tweaked to match to the omicron variant in healthy adults. Continue reading
Jan 13 As omicron rages, COVID-19 pill stymied by shortages By Matthew Perrone, Associated Press Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections. Continue reading
Jan 05 CDC advisers endorse Pfizer COVID boosters for younger teens By Lauran Neergaard, Mike Stobbe, Associated Press An influential government advisory panel is recommending COVID-19 boosters for younger teens. Boosters already are recommended for everyone 16 and older. Continue reading
Jan 03 As omicron surges, FDA expands Pfizer boosters for more teens By Lauran Neergaard, Associated Press The U.S. is expanding COVID-19 boosters as it confronts the omicron surge. The Food and Drug Administration on Monday allowed extra Pfizer shots for children as young as 12. Continue reading